Skip to content
Inciteful Med

Understanding Von Willebrand Disease: Validation & Orientation

Last updated:

Von Willebrand Disease (VWD) is the most common inherited bleeding disorder, caused by a problem with Von Willebrand Factor (VWF), a protein that helps blood clot. It ranges from mild (Type 1) to severe (Type 3). While often undiagnosed, it is highly manageable, and most patients have a normal life expectancy.

Key Takeaways

  • • Von Willebrand Disease is the most common inherited bleeding disorder, affecting about 1% of the population.,

Getting a diagnosis of Von Willebrand Disease (VWD) can feel overwhelming, but for many, it is finally the “missing piece” that explains years of unexplained bruising, heavy periods, or prolonged bleeding from minor cuts [1][2]. VWD is the most common inherited bleeding disorder, affecting approximately 1% of the population [3][1]. Despite how common it is, it is frequently underdiagnosed because symptoms can vary significantly from person to person [1][4].

Understanding Your “Blood Glue”

To understand VWD, it helps to think of the Von Willebrand Factor (VWF) as having two vital jobs in your blood:

  1. The Glue (Platelet Adhesion): When you are injured, VWF acts like a high-strength glue that helps platelets (tiny blood cells) stick to the site of the injury to form a plug and stop the bleeding [5].
  2. The Carrier (Factor VIII Protection): VWF also acts as a protective “carrier” for Factor VIII, another essential protein needed for blood clotting [6][7]. Without VWF to shield it, Factor VIII would be broken down too quickly by the body and wouldn’t be available when you need it to form a stable clot [6][7].

In VWD, your body either doesn’t make enough of this “glue” or the glue it makes doesn’t work correctly [4].

VWD vs. Hemophilia A

Because VWF and Factor VIII work so closely together, VWD is sometimes confused with Hemophilia A [7].

  • Hemophilia A is a primary shortage of Factor VIII itself [7].
  • VWD is a problem with the Von Willebrand Factor, which then causes a secondary drop in Factor VIII because there isn’t enough VWF to protect it [6][7].

Specifically, a subtype called Type 2N VWD is often misdiagnosed as Hemophilia A because the VWF is present but cannot “carry” the Factor VIII properly [8][9]. Getting the correct diagnosis is essential because the treatments for these two conditions are different [7][9].

The Spectrum of Severity

VWD is not a “one size fits all” condition. It exists on a wide spectrum, categorized into three main types:

  • Type 1 (Most Common): You have low levels of VWF. Symptoms are often mild, and many people only discover they have it during surgery or after a significant injury [10][2].
  • Type 2 (Qualitative): You have enough VWF, but it doesn’t work the way it should [11][12].
  • Type 3 (Rare and Severe): You have very little or no VWF at all. This often involves more frequent and severe bleeding, including bleeding into muscles or joints [13][14].

Why Is It Often Missed?

It is very common for VWD patients to go years without a diagnosis [1]. This happens for several reasons:

  • Variable Symptoms: Some people only bleed during major events like childbirth or surgery [1][15].
  • Hormonal Changes: VWF levels can change based on age, stress, or even the use of birth control, which can make test results inconsistent [16][4].
  • Blood Type: People with Type O blood naturally have lower levels of VWF, which can make it harder to tell the difference between a normal level and a mild case of VWD [17][18].

Looking Forward

While VWD is a lifelong condition, it is highly manageable [19]. With a proper care team and a treatment plan in place for surgeries or injuries, most people with VWD live full, active lives with a normal life expectancy [19][20]. Your diagnosis is not a limitation; it is the tool that allows you and your doctors to keep you safe [20][21].

Frequently Asked Questions

What does Von Willebrand Factor do in the body?
Von Willebrand Factor (VWF) acts like "glue" that helps platelets stick to injury sites to stop bleeding. It also acts as a protective carrier for Factor VIII, another clotting protein. If VWF is low or not working, your blood cannot form stable clots efficiently.
What is the difference between Von Willebrand Disease and Hemophilia A?
Hemophilia A is a primary shortage of Factor VIII. In VWD, the problem is with the Von Willebrand Factor, which causes a secondary drop in Factor VIII because there isn't enough VWF to protect it. Distinguishing between them, especially Type 2N VWD, is crucial because treatments differ.
What are the different types of Von Willebrand Disease?
Type 1 involves low levels of VWF and is often mild. Type 2 means you have enough VWF, but it doesn't function correctly. Type 3 is the most severe and rare form, where there is little to no VWF, leading to significant bleeding risks.
Does having Type O blood affect my VWD diagnosis?
Yes. People with Type O blood naturally have lower levels of Von Willebrand Factor compared to other blood types. This can sometimes make it difficult for doctors to distinguish between a normal variation and a mild case of VWD.
Why does it take so long to get diagnosed with VWD?
VWD is often missed because symptoms vary widely; some people only bleed excessively during major events like surgery or childbirth. Additionally, VWF levels can fluctuate due to stress, hormones, or age, leading to inconsistent test results.

Questions for Your Doctor

  • • Based on my symptoms and family history, what is my specific VWD subtype (Type 1, 2, or 3)?
  • • How do my Von Willebrand Factor (VWF) and Factor VIII levels compare to the normal range?
  • • Is my blood type (e.g., Type O) influencing my test results or bleeding risk?
  • • What steps should we take to prevent bleeding during future surgeries, dental work, or childbirth?
  • • Are there specific activities or medications (like aspirin or ibuprofen) I should avoid?
  • • If I have Type 2N, how do we distinguish it from Hemophilia A to ensure I get the right treatment?

Questions for You

  • • What are the most common bleeding symptoms you or your child have experienced (e.g., frequent nosebleeds, heavy periods, or easy bruising)?
  • • Have you ever had unexpected or prolonged bleeding after a surgery, dental procedure, or injury?
  • • Do other members of your family have a history of bleeding issues, even if they were never formally diagnosed?
  • • How have these symptoms affected your daily life or your confidence in physical activities?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    [Diagnosing von Willebrand disease].

    Vojdeman FJ, Philips M, Funding E, Gøtze JP

    Ugeskrift for laeger 2019; (181(16)).

    PMID: 31036151
  2. 2

    Bleeding Symptoms and von Willebrand Factor Levels: 30-Year Experience in a Tertiary Care Center.

    Moonla C, Akkawat B, Kittikalayawong Y, et al.

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2019; (25()):1076029619866916 doi:10.1177/1076029619866916.

    PMID: 31359769
  3. 3

    Von Willebrand disease: classification and epidemiology.

    Castaman G, Bramante Federici A

    Haematologica 2026; (111(1)):26-34 doi:10.3324/haematol.2024.286058.

    PMID: 41496701
  4. 4

    von Willebrand disease.

    Seidizadeh O, Eikenboom JCJ, Denis CV, et al.

    Nature reviews. Disease primers 2024; (10(1)):51 doi:10.1038/s41572-024-00536-8.

    PMID: 39054329
  5. 5

    Closing the gap - detection of clinically relevant von Willebrand disease in emergency settings through an improved algorithm based on rotational Thromboelastometry.

    Topf HG, Strasser ER, Breuer G, et al.

    BMC anesthesiology 2019; (19(1)):10 doi:10.1186/s12871-018-0672-8.

    PMID: 30630422
  6. 6

    Physiological Roles of the von Willebrand Factor-Factor VIII Interaction.

    Kiouptsi K, Reinhardt C

    Sub-cellular biochemistry 2020; (94()):437-464 doi:10.1007/978-3-030-41769-7_18.

    PMID: 32189311
  7. 7

    Laboratory Testing for von Willebrand Factor: Factor VIII Binding for the Diagnosis or Exclusion of Type 2N von Willebrand Disease: An Update.

    Favaloro EJ, Mohammed S, Vong R, Pasalic L

    Methods in molecular biology (Clifton, N.J.) 2023; (2663()):679-691 doi:10.1007/978-1-0716-3175-1_45.

    PMID: 37204745
  8. 8

    Von Willebrand disease type 2N: An update.

    Seidizadeh O, Peyvandi F, Mannucci PM

    Journal of thrombosis and haemostasis : JTH 2021; (19(4)):909-916 doi:10.1111/jth.15247.

    PMID: 33497541
  9. 9

    Are Iranian patients with von Willebrand disease type 2N properly differentiated from hemophilia A and do they receive appropriate treatment?

    Seidi Zadeh O, Ahmadinejad M, Amoohossein B, Homayoun S

    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2020; (31(6)):382-386 doi:10.1097/MBC.0000000000000932.

    PMID: 32815913
  10. 10

    [Diagnosis and treatment of von Willebrand disease].

    Nagae C

    [Rinsho ketsueki] The Japanese journal of clinical hematology 2025; (66(9)):1146-1157 doi:10.11406/rinketsu.66.1146.

    PMID: 41034067
  11. 11

    Unraveling the Influence of Common von Willebrand factor variants on von Willebrand Disease Phenotype: An Exploratory Study on the Molecular and Clinical Profile of von Willebrand Disease in Spain Cohort.

    Borràs N, Garcia-Martínez I, Batlle J, et al.

    Thrombosis and haemostasis 2020; (120(3)):437-448 doi:10.1055/s-0040-1702227.

    PMID: 32135566
  12. 12

    Utility of the von Willebrand factor collagen binding assay in the diagnosis of von Willebrand disease.

    Favaloro EJ

    American journal of hematology 2017; (92(1)):114-118 doi:10.1002/ajh.24556.

    PMID: 27622788
  13. 13

    Health-Related Quality of Life in Adult Patients With von Willebrand Disease From Germany: Results of the WIL-QoL Study.

    von Mackensen S, Moorthi C, Fischer R, et al.

    Haemophilia : the official journal of the World Federation of Hemophilia 2025; doi:10.1111/hae.70073.

    PMID: 41313635
  14. 14

    A 4-Week-Old Female Infant with Type 3 von Willebrand Disease Presenting with Nosebleeds and Uncontrolled Bleeding Following Surgical Frenectomy: A Clinical Case.

    Zima A, Iwaniec T, Zdziarska J, et al.

    The American journal of case reports 2025; (26()):e946625 doi:10.12659/AJCR.946625.

    PMID: 40418685
  15. 15

    Von Willebrand Disease and Pregnancy: Management Protocol From Labor to the Postpartum Period.

    Muñoz Vargas BA, Contreras Valero SJ, Aragon Mendoza RL, et al.

    Cureus 2024; (16(2)):e53465 doi:10.7759/cureus.53465.

    PMID: 38435184
  16. 16

    (Un) Diagnosing von Willebrand disease.

    Brenner MK, Christopherson PA, Flood VH

    Hematology. American Society of Hematology. Education Program 2025; (2025(1)):127-130 doi:10.1182/hematology.2025000697.

    PMID: 41348003
  17. 17

    Unravelling the spectrum of von Willebrand factor variants in quantitative von Willebrand disease: results from a German cohort study.

    Krahforst A, Yadegari H, Pavlova A, et al.

    Journal of thrombosis and haemostasis : JTH 2024; (22(11)):3010-3034 doi:10.1016/j.jtha.2024.06.026.

    PMID: 39002731
  18. 18

    Development and internal validation of a clinical prediction model for individualized dosing of BAY 81-8973, A full-length recombinant factor VIII, in pediatric patients with haemophilia A.

    He H, Huang K, Cheng X, et al.

    Thrombosis research 2023; (232()):6-14 doi:10.1016/j.thromres.2023.10.009.

    PMID: 39492253
  19. 19

    Endothelial Function in Patients With Von Willebrand Disease.

    Noone S, Schubert R, Fichtlscherer S, et al.

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2021; (27()):1076029620984546 doi:10.1177/1076029620984546.

    PMID: 33448867
  20. 20

    Type 2M Von Willebrand Disease: A Case Report.

    Ghosh S, Bendi VS, Krishnamurthy J, et al.

    Cureus 2018; (10(8)):e3112 doi:10.7759/cureus.3112.

    PMID: 30338187
  21. 21

    Bleeding-related hospitalization in patients with von Willebrand disease and the impact of prophylaxis: Results from national registers in Sweden compared with normal controls and participants in the von Willebrand Disease Prophylaxis Network.

    Holm E, Carlsson KS, Lövdahl S, et al.

    Haemophilia : the official journal of the World Federation of Hemophilia 2018; (24(4)):628-633 doi:10.1111/hae.13473.

    PMID: 29626372

This guide explains the basics of Von Willebrand Disease and its types for educational purposes. Always consult a hematologist for accurate diagnosis and a personalized treatment plan.

Stay up to date

Get notified when new research about Von Willebrand Disease is published.

No spam. Unsubscribe anytime.